Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors
Abstract SARS-CoV-2 is now endemic, with infections commonplace. While much of the population now has immunity, some subsets remain at risk. For such individuals, small-molecule antivirals are the frontline treatment. However, studies have identified resistance-conferring mutations to these compound...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2026-05-01
|
| coleção: | Nature Communications |
| Acesso em linha: | https://doi.org/10.1038/s41467-026-73444-y |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|